Insider sale
APOLLOMICS INC.
$19.70M
16.22M shares
What this filing means
ORBIMED ADVISORS II LTD plans to sell 16.22M shares of APOLLOMICS INC. valued at approximately $19.70M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/27/2023ACC: 0000947871-23-001108
16.22M
Shares to sell
$19.70M
Approx. market value
9.52M
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Business combination
Cash
3/29/2023
9.52MTotal acquired9.52M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/29/2023 | Business combination Cash | 9.52M | — |
| Total | 9.52M | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.70M
Market value
$8.38M
11/16/2023
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
9.52M
Market value
$11.32M
11/27/2023
Total
Units
16.22M
Value
$19.70M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/16/2023 | 6.70M | $8.38M | — | Completed |
| Planned — Approximate Date | ||||
11/27/2023 | 9.52M | $11.32M | Nasdaq Stock Market | Planned |
| Total | 16.22M | $19.70M | ||